Cargando…
Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature
BACKGROUND: Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely prescribed for the treatment of osteoporosis and are also used in patients with multiple myeloma and metastatic breast or prostate cancer for avoiding bone reabsorption and fractures that result in increas...
Autores principales: | Gavaldá, Carmen, Bagan, Jose V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medicina Oral S.L.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867198/ https://www.ncbi.nlm.nih.gov/pubmed/26827066 http://dx.doi.org/10.4317/medoral.21001 |
Ejemplares similares
-
Osteonecrosis of the jaws in patients treated with bisphosphonates
por: Ata-Ali, Fadi, et al.
Publicado: (2012) -
Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature
por: Sigua-Rodriguez, Eder Alberto, et al.
Publicado: (2014) -
Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: Associated clinical characteristics
por: Bagan, Leticia, et al.
Publicado: (2017) -
Serum levels of RANKL and OPG, and the RANKL/OPG
ratio in bisphosphonate-related osteonecrosis of the jaw: Are they
useful biomarkers for the advanced stages of osteonecrosis?
por: Bagan, Leticia, et al.
Publicado: (2017) -
Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw
por: Vescovi, Paolo, et al.
Publicado: (2014)